Nasopharyngeal carcinoma: Difference between revisions
No edit summary |
|||
Line 3: | Line 3: | ||
{{CMG}} {{AE}}{{MJM}}, {{Faizan}} | {{CMG}} {{AE}}{{MJM}}, {{Faizan}} | ||
{{SK}}: Rhinopharyngeal carcinoma, NPC | {{SK}}: Rhinopharyngeal carcinoma, NPC, nasopharynx cancer | ||
==[[Nasopharyngeal carcinoma overview|Overview]]== | ==[[Nasopharyngeal carcinoma overview|Overview]]== |
Revision as of 13:47, 15 September 2015
For patient information click here
Nasopharyngeal carcinoma Microchapters |
Differentiating Nasopharyngeal carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Nasopharyngeal carcinoma On the Web |
American Roentgen Ray Society Images of Nasopharyngeal carcinoma |
Risk calculators and risk factors for Nasopharyngeal carcinoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Michael Maddaleni, B.S., Faizan Sheraz, M.D. [2]
Synonyms and keywords:: Rhinopharyngeal carcinoma, NPC, nasopharynx cancer
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Nasopharyngeal carcinoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Staging | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies